Related Experiment Video
Updated: Jun 23, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or
Leandro L Coutinho1,2, Elise L Femino1, Ana L Gonzalez1
1Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
Nitric oxide (NO) and reactive nitrogen species (RNS) are key in cancer. Understanding their chemical biology and spatial distribution in the tumor microenvironment (TME) is crucial for developing targeted therapies.
Area of Science:
- Chemical biology
- Cancer research
- Molecular biology
Background:
- Nitric oxide (NO) and reactive nitrogen species (RNS) have critical biological functions determined by their chemical properties.
- Their spatial distribution is vital for understanding their roles in biological processes, particularly in cancer.
Purpose of the Study:
- To establish a framework for the chemical biology of NO and RNS in cancer.
- To explore the concentration-dependent signaling of NO and its influence on oncogenic properties.
- To investigate the interplay between NOS2 and COX-2 in cancer progression and the tumor microenvironment (TME).
Main Methods:
- Review of existing literature on NO and RNS chemistry and biology in cancer.
- Analysis of concentration-dependent effects of NO in cancer cell signaling.
- Examination of the spatial expression and co-expression patterns of NOS2 and COX-2 in the TME.
- Discussion of therapeutic strategies targeting NO and RNS pathways.
Main Results:
- NO influences cancer cell proliferation, metastasis, chemotherapy resistance, and immune suppression.
- Increased NOS2 expression correlates with poor survival, and it can crosstalk with COX-2 to promote cancer progression.
- NOS2 and COX-2 co-expression creates a feed-forward loop driving immunosuppression and metastasis in ER-negative breast cancer.
- Spatial analysis reveals orthogonal expression of NOS2 and COX-2 in distinct TME niches, requiring IFN-γ and cytokine-releasing cells.
Conclusions:
- Understanding the chemical biology and spatial distribution of NO and RNS is essential for cancer research.
- Targeting NOS2 and COX-2, potentially with compounds from cruciferous vegetables, offers therapeutic avenues.
- These insights are valuable for developing targeted therapies and preventive strategies against cancer.
More Related Videos
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibition of Cdk Activity
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...